Category: MAKO Surgical Corp.
Here's a look at some of the top regulatory stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit
, Becton Dickinson & Co.
, DePuy Synthes
, GenCell Biosystems
, Johnson & Johnson
, Kimberly-Clark Worldwide Inc.
, MAKO Surgical Corp.
, Stryker Corp.
, Valeant Pharmaceuticals
, 3M Corp.
, Allergan Inc.
Stryker says Mako Surgical's sales are not as strong as hoped for when the orthopedics giant spent $1.7 billion on the robot-assisted surgery firm last year.
Merger and acquisition activity in the medtech industry contracted 13% in 2013, with 41 deals worth a cumulative $14.3 billion coming in for the year, according to analysis from PricewaterhouseCoopers.
Total deal volume in the medical device industry contracted by about 13% in 2013, according to new analysis from audit shop PricewaterhouseCoopers.
Stryker Corp. says it closed the $1.7 billion buyout of robotic surgery company Mako Surgical today.
Mako Surgical's shareholders approve Stryker Corp.'s $1.65 billion acquisition bid.
Mako Surgical says it's settled 1 of 2 sets of lawsuits filed by shareholders ahead of its $1.65 billion buyout by Stryker Corp.
Company officials at Mako Surgical discuss the company's Q2 2013 earnings release. Mako posted Q3 losses of $21.3 million, or 45¢ per share, on sales of $22.8 million for the 3 months ended Sept. 30, 2013